Objective Randomized controlled trials comparing tocilizumab and baricitinib in patients with
coronavirus disease 2019 (COVID-19) are needed. This was an open-label, randomized …

This systematic review aimed to reevaluate the available evidence of the use of biologics as
treatment candidates for the treatment of severe and advanced COVID-19 disease; what are …

Introduction Post-acute sequelae of COVID-19 seem to be an emerging global crisis.
Machine learning radiographic models have great potential for meticulous evaluation of post …

At the beginning of the pandemic, we observed that lithium carbonate had a positive effect
on the recovery of severely ill patients with COVID-19. Lithium is able to inhibit the …

Purpose To describe the effect of dexamethasone and tocilizumab on regional lung
mechanics over admission in all mechanically ventilated COVID-19 patients. Materials and …

OBJECTIVE: Real-life data for vaccination against COVID-19 are sorely needed. This was a
population-based analysis aiming at investigating the hospitalization risk for COVID-19 of …

Purpose: Tocilizumab is associated with positive outcomes in severe COVID-19. We wanted
to describe the characteristics of nonresponders to treatment. Methods: This was a …

Objective The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of
confirmed cases and deaths globally. The purpose of this study was to investigate the …

The emergence and spread of 2019 coronavirus disease (COVID-19) are causing a growing
global public health crisis. Despite advances in treatment, vaccination remains the best way …

Objective COVID-19 outcome may be less favourable in patients with inflammatory
rheumatic and musculoskeletal diseases (RMD) receiving immunosuppressive therapy. We …